» Articles » PMID: 24662940

Isolation of Circulating Tumor Cells by Dielectrophoresis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2014 Mar 26
PMID 24662940
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Dielectrophoresis (DEP) is an electrokinetic method that allows intrinsic dielectric properties of suspended cells to be exploited for discrimination and separation. It has emerged as a promising method for isolating circulation tumor cells (CTCs) from blood. DEP-isolation of CTCs is independent of cell surface markers. Furthermore, isolated CTCs are viable and can be maintained in culture, suggesting that DEP methods should be more generally applicable than antibody-based approaches. The aim of this article is to review and synthesize for both oncologists and biomedical engineers interested in CTC isolation the pertinent characteristics of DEP and CTCs. The aim is to promote an understanding of the factors involved in realizing DEP-based instruments having both sufficient discrimination and throughput to allow routine analysis of CTCs in clinical practice. The article brings together: (a) the principles of DEP; (b) the biological basis for the dielectric differences between CTCs and blood cells; (c) why such differences are expected to be present for all types of tumors; and (d) instrumentation requirements to process 10 mL blood specimens in less than 1 h to enable routine clinical analysis. The force equilibrium method of dielectrophoretic field-flow fractionation (DEP-FFF) is shown to offer higher discrimination and throughput than earlier DEP trapping methods and to be applicable to clinical studies.

Citing Articles

High-gradient microstructured hybrid microfluidic chip for rare tumor cell capture.

Ding W, Ye W, Liu H, Yang J, Chu C, Zhu H Anal Bioanal Chem. 2025; .

PMID: 40085212 DOI: 10.1007/s00216-025-05825-z.


iDEP-based single-cell isolation in a two-dimensional array of chambers addressed by easy-to-align wireless electrodes.

Rathnaweera T, Anand R Lab Chip. 2025; 25(6):1600-1610.

PMID: 39950224 PMC: 11826382. DOI: 10.1039/d4lc00976b.


Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism.

Bergmann L, Afflerbach A, Yuan T, Pantel K, Smit D Semin Immunopathol. 2025; 47(1):14.

PMID: 39893314 PMC: 11787191. DOI: 10.1007/s00281-025-01042-z.


Microfluidics engineering towards personalized oncology-a review.

Mishra S, Kumarasamy M In Vitro Model. 2025; 2(3-4):69-81.

PMID: 39871996 PMC: 11756504. DOI: 10.1007/s44164-023-00054-z.


Advances in microfluidic platforms for tumor cell phenotyping: from bench to bedside.

Joshi R, Ahmadi H, Gardner K, Bright R, Wang W, Li W Lab Chip. 2025; 25(5):856-883.

PMID: 39774602 PMC: 11859771. DOI: 10.1039/d4lc00403e.


References
1.
Henslee E, Sano M, Rojas A, Schmelz E, Davalos R . Selective concentration of human cancer cells using contactless dielectrophoresis. Electrophoresis. 2011; 32(18):2523-9. DOI: 10.1002/elps.201100081. View

2.
Park J, Lee J, Lee J, Jeong H, Oh J, Kim Y . Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood. Anal Chem. 2012; 84(17):7400-7. DOI: 10.1021/ac3011704. View

3.
Salmanzadeh A, Sano M, Shafiee H, Stremler M, Davalos R . Isolation of rare cancer cells from blood cells using dielectrophoresis. Annu Int Conf IEEE Eng Med Biol Soc. 2013; 2012:590-3. DOI: 10.1109/EMBC.2012.6346000. View

4.
Vykoukal J, Vykoukal D, Freyberg S, Alt E, Gascoyne P . Enrichment of putative stem cells from adipose tissue using dielectrophoretic field-flow fractionation. Lab Chip. 2008; 8(8):1386-93. PMC: 2726253. DOI: 10.1039/b717043b. View

5.
Pethig R, Menachery A, Pells S, De Sousa P . Dielectrophoresis: a review of applications for stem cell research. J Biomed Biotechnol. 2010; 2010:182581. PMC: 2871555. DOI: 10.1155/2010/182581. View